AboutContactTerms & Privacy
© 2024 Coverager
All Rights Reserved

ImmuneOnco Biopharma

Tumor immunotherapy product developer engaged in the development and research of tumor immunotherapy products.

Headquarters
Shanghai, Shanghai, China
Founded
2015
Operating Status
Active
Ownership Type
Business Model
Links
Number of funding rounds 7
Number of investors 16
Total funding amount $147.21M
Date Amount Stage Investors

Clients Only Feature

Client? Sign in to access this feature.
Not a client? Learn more about Coverager Research.